Designed to change medical practice - the landmark SELUTION DeNovo Study achieves enrollment of over 1,600 patients
For full press release: https://t.co/FDxIERse7P
To learn about the study: https://t.co/txDLU3yf0W
#SELUTIONDeNovo#clinicaltrials#medicaldevices#SELUTIONSLR
Very productive & interactive Selution DeNovo UK investigator meeting today in London. Big thanks to @DrPeterOKane for hosting & all those who attended
Join us on Nov 23rd at 17:00 CET, for UNCAGE episode 3:
UNCAGE Coronaries, UNCAGE Chronic Total Occlusions
Register now at the following link: https://t.co/zsGWtpAvkL
We look forward to your participation!
#UNCAGE#DigitalEducation#SelutionSLR#DCB#DEB#medicaldevices
Tjun Tang reports 24-month data from PRESTIGE, noting sustained efficacy and safety of the Selution SLR sirolimus-coated balloon in #CLTI patients from Singapore
#VIVA22@VIVAPhysicians
BIG #ANNOUNCEMENT! We’re excited to announce our acquisition of @MedallianceSA, a Switzerland-based medical technology company pioneering key innovations for coronary and peripheral arterial disease. More information below! #Cordis#FreetoImagine https://t.co/9N9vLwEaaW
@SELUTION_DeNovo Study hitting the stage at #TCT2022
CoPI Christian Spaulding presenting this revolutionary trial, the largest DCB trial ever @Rana_Saitta @MedallianceSA